Recent Company News

• 05:41 AM ET Mar 30, 2026
  

  BioGaia publishes Annual and Sustainability Report 2025 (SEK 117.00, -0.10)

• 05:04 AM ET Mar 20, 2026
  

  BioGaia announces the publication of a 10-year follow-up study of our probiotic strain, Limosilactobacillus reuteri (SEK 113.90, +0.30)

• 08:06 AM ET Mar 17, 2026
  

  BioGaia exercises option to acquire remaining 20% of shares in Nutraceutics (SEK 115.70, +0.90)

• 06:06 AM ET Feb 26, 2026
  

  BioGaia extends long-standing distribution partnership with Ewopharma (SEK 108.40, +0.70)

• 04:41 AM ET Feb 12, 2026
  

  Transcript Intelligence: BioGaia Q4 Earnings Guidance

• 04:40 AM ET Feb 12, 2026
  

  Transcript Intelligence: BioGaia Q4 Earnings Themes

• 04:40 AM ET Feb 12, 2026
  

  Transcript Intelligence: BioGaia Q4 Earnings Q&A

• 04:31 AM ET Feb 03, 2026
  

  StreetAccount Summary - Trading higher/lower: EU mid-morning

• 02:24 AM ET Feb 12, 2026
  

  BioGaia reports Q4 EPS SEK0.98 vs FactSet SEK0.80 [3 est, SEK0.79-0.81] (SEK 105.20, 0.00)